Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer : Prospective Cohort Comparing the Recommandation for Patient Care According to the Immunoscore® With the Standard Care Decision.
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Evaluate the patient care recommandation induced by the IMMUNOSCORE® result
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• age between 18 and 80 inclusive;
• histologically confirmed colon adenocarcinoma;
• having undergone a curative resection of stage I, II or III colorectal cancer;
• diagnosed T1 / T2 / T3 / T4 and N0 / N1 / N2;
• eligible to receive 6 months of adjuvant chemotherapy;
• having given free, informed and written consent;
• agreeing to the use of a tumor sample for research purposes;
• being affiliated to a social security system.
Locations
Other Locations
France
Hôpital Européen
NOT_YET_RECRUITING
Marseille
Hopital Saint Joseph
RECRUITING
Marseille
Contact Information
Primary
Cécile BIELMANN
cbielmann@hopital-saint-joseph.fr
04 88 73 10 70
Time Frame
Start Date: 2022-04-04
Estimated Completion Date: 2028-04
Participants
Target number of participants: 100
Treatments
Experimental: IMMUNOSCORE®
Related Therapeutic Areas
Sponsors
Leads: Hospital St. Joseph, Marseille, France